Medical ProductsCompany
Oxford Immunotec Global M&A Summary
Oxford Immunotec Global has acquired 3 companies of its own.
Oxford Immunotec Global’s largest acquisition to date was in 2016, when it acquired Imugen for $22M. Oxford Immunotec Global has acquired in 2 different US states. The Company’s most targeted sectors include life science (34%) and medical products (34%).
Oxford Immunotec Global Ownership
Who owns Oxford Immunotec Global?
Oxford Immunotec Global is owned by Revvity. It was acquired on January 7, 2021.
Oxford Immunotec Global Business Overview
Where is Oxford Immunotec Global headquartered?
Oxford Immunotec Global is headquartered in Abingdon, United Kingdom.
What is Oxford Immunotec Global’s revenue?
Oxford Immunotec Global disclosed revenue of 74M USD for 2019 and 60M USD for 2018.
How many employees does Oxford Immunotec Global have?
Oxford Immunotec Global has 260 employees.
What sector is Oxford Immunotec Global in?
Oxford Immunotec Global is a medical products company.
When was Oxford Immunotec Global founded?
Oxford Immunotec Global was founded in 2002.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 3
- Total Countries Invested 1